{"ticker": {"uuid": "1dd3c0f0-fd4e-4e4b-a276-ed4392d3ae8e", "symbol": "POM", "name": "POMDOCTOR LIMITED American Depositary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Pharmaceutical Retailers"}, "articles": [{"title": "POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-limited-advances-healthcare-data-120000932.html", "source_name": "PR Newswire", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED (POM) expands AI-powered chronic disease data platform", "summary": "POMDOCTOR LIMITED is strengthening its AI-powered chronic disease management platform by building a comprehensive healthcare data ecosystem. The company leverages real-world data from wearables, remote monitoring, and patient interactions to improve AI models and provide personal", "url": "https://www.stocktitan.net/sec-filings/POM/6-k-pomdoctor-ltd-current-report-foreign-issuer-d6275cf75d23.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:13:36", "published_display": "15 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor Connects Wearables, Doctors and Health Data for AI Care", "summary": "Pomdoctor (NASDAQ: POM) is advancing its healthcare data strategy to enhance AI-powered chronic disease management by integrating real-world data from various sources including wearables, remote patient monitoring systems, and physician interactions. The company aims to build a c", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-advances-healthcare-data-asset-strategy-to-cs4d7f9ibyak.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:13:36", "published_display": "15 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor Says It Has Regained Compliance with Nasdaq Minimum Bid Price Rule", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-says-regained-compliance-nasdaq-134033773.html", "source_name": "MT Newswires", "published_at": "2026-07-13T13:40:33+00:00", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor regains compliance with Nasdaq minimum bid price rule", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQcmdpRlZ5QXJBY1RlUDRWUDNoZ3diMS1Ha1J6N0h2TW5Ha05sYm51LWZuX1lPTHN3Z3JvM1d1TTd4bmFxeWRTeTVpTFd2X3Z0dmhqYmlhNWJ4WGRSLVg5UlBGZE9Bdmc5V3kxU0NKSGZ5RnpZdm95bGc0T1lKSUwtc1hydGZ4LWNEOVBFaFdGTURtTHQwS2pLT3ZMRGpXUGJGRThLMEhUMkQtVVY4SXhPY3BrdjZaTTZVYmdESQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:11:56+00:00", "published_display": "13 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement", "summary": "POMDOCTOR LIMITED (NASDAQ: POM) announced its regaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This follows a previous notification on January 29, 2026, when the company's American Depositary Shares fell below the threshold. The stock has since", "url": "https://finance.yahoo.com/markets/stocks/articles/pomdoctor-limited-regains-compliance-nasdaq-120000205.html", "source_name": "Market source", "published_at": "2026-07-13T12:09:52", "published_display": "13 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com", "summary": "Pomdoctor Limited has regained compliance with Nasdaq's minimum bid price requirement after its American Depositary Shares maintained a closing bid price of $1.00 or higher for 10 consecutive business days. The company had previously received a deficiency notice in January 2026. ", "url": "https://ca.investing.com/news/stock-market-news/pomdoctor-regains-compliance-with-nasdaq-minimum-bid-price-rule-93CH-4731049", "source_name": "Investing.com Canada", "published_at": "2026-07-13T12:09:52", "published_display": "13 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-limited-continues-advance-ai-120000708.html", "source_name": "PR Newswire", "published_at": "2026-07-09T12:00:00+00:00", "published_display": "09 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor pushes AI-powered chronic disease monitoring with wearables", "summary": "POMDOCTOR (NASDAQ: POM) has announced its continued advancement in AI-enabled chronic disease management, integrating AI analytics, remote patient monitoring, and wearables to create a predictive, continuous, and personalized healthcare ecosystem. The company highlights the signi", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-continues-to-advance-ai-enabled-chronic-disease-aja11bf6o303.html", "source_name": "Stock Titan", "published_at": "2026-07-09T11:39:41", "published_display": "09 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of POMDOCTOR LIMITED \u2013 NASDAQ:POM", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQal9NaUtRV3NUWklWZUJ4MjNKbGhYS1JKSU5GbFRjLWFESE5sVjZqbmhoMllMUklORktMRW5jRG1Ld1J3UnFuT0dpczNmcENQR0lrMk5BWWdNM0pCNEx1VHZ6MWlMYW9RV2Q0QTZnMEtjRnpwMWphZWEyOWdHdENnR24xVnBsUlRQTlpRTURFeXhKUjZ6Mko5eEJNczgyaEkzMkJOY1Zn?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:15:02+00:00", "published_display": "04 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services", "summary": "POMDOCTOR LIMITED (NASDAQ: POM) has announced a strategic upgrade, repositioning itself as a foundational infrastructure provider for predictive healthcare data and services. The company aims to evolve from a traditional online healthcare platform to an AI-enabled ecosystem that ", "url": "https://www.manilatimes.net/2026/07/02/tmt-newswire/pr-newswire/pomdoctor-limited-announces-strategic-upgrade-toward-infrastructure-for-predictive-healthcare-data-and-services/2377494/amp", "source_name": "The Manila Times", "published_at": "2026-07-02T18:09:14", "published_display": "02 Jul 2026 18:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce", "summary": "Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and its officers. The lawsuit alleges that PomDoctor engaged in a fraudulent stock promotion scheme involving misinformation and coordinated dumping of shares by insiders", "url": "https://natlawreview.com/press-releases/pom-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-pomdoctor-4", "source_name": "The National Law Review", "published_at": "2026-07-01T05:10:30", "published_display": "01 Jul 2026 05:10", "sentiment": "negative", "sentiment_pct": 10, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for PomDoctor Ltd (POM) for FY2024 and FY2023, categorized by business segment. It details the proportion of revenue generated from prescription drugs, over-the-counter medicines, traditional Chinese medicine, online consultation, and med", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:20", "published_display": "18 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of PomDoctor Ltd's (POM) dividend and stock split history. It notes that no dividends have been distributed by the company over the past five years. The only recorded stock split event for POM is a 18-to-1 merger on May 28, 2026.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:36", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor to implement 1-for-18 reverse ADS split June 22 By Investing.com", "summary": "Pomdoctor Limited announced a 1-for-18 reverse American Depositary Share (ADS) split, effective June 22, 2026. This action will change the ADS ratio from one ADS representing one-sixth of a Class A ordinary share to one ADS representing three Class A ordinary shares. The reverse ", "url": "https://za.investing.com/news/stock-market-news/pomdoctor-to-implement-1for18-reverse-ads-split-june-22-93CH-4332380", "source_name": "Investing.com South Africa", "published_at": "2026-06-17T23:40:49", "published_display": "17 Jun 2026 23:40", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Institutional Confidence", "summary": "This article provides an \"Institutional Confidence\" score for PomDoctor Ltd (POM), detailing shares held by various institutions like XTX Markets LLC, Millennium Management LLC, and UBS Financial Services, Inc. It shows a previous score of 0.00 with no change, indicating a stable", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T11:39:53", "published_display": "17 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of PomDoctor Ltd (POM), noting the current stock price, market capitalization, and the lack of disclosed relevant data for key valuation metrics such as P/E, P/B, P/S, and P/CF ratios. It highlights that the company has not yet provided ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T11:39:53", "published_display": "17 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSTNfd0Y1M3VRT2JZSnU3ZjUxdXpmVFplMVRVZWFwdHY2blJfMEh3WElKZXFTTGNSamlhZkFuVUR4MHdPbGYyR2tkM0VSamFZRTdXdklhRHVsU0hxTm5zeU9YSHd5V3FDcHRHS1VyVGhiaWVXQTZsYjJ1c2hFQ2hDWWJXMHB2UU8wUjZYZm5KRUR0WUlsRUZrSkRhVjhJOWRoTTlxUw?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor to implement 1-for-18 reverse ADS split June 22", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOWUs3VDRZWWxSNEpmR1ctWm5qTHl5SmRUNmZWWWVVdm55bndNN1V4RzNGRkxlaWdfTVJGdHhQbUI5MnFlckVTNGRkTnpNRmpfbnk5cTZ4OEduYTBfaUVfU2lEdGROX09QQ0pxaEx3RlUzeEtLdVJmdTkwcktiaWtUcjE1ZV9yUzVqNmZEdnQ3LVNsSEVuUFQxVWwwQ1o0M21JYkdFeC11dGdqWGZ5Mm4zVF93?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Own Pomdoctor ADSs? 18 old shares will become 1 on June 22", "summary": "POMDOCTOR (NASDAQ:POM) has announced that its ADS-to-Class A ordinary share ratio will change effective June 22, 2026. This adjustment means that 18 existing ADSs will be consolidated into 1 new ADS, effectively a one-for-eighteen reverse ADS split. The change will happen automat", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-announces-ads-ratio-change-to-be-effective-on-june-v7k6q8fecld4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T04:10:02", "published_display": "16 Jun 2026 04:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM Stockholder Alert: Robbins LLP Reminds Investors of the Clas", "summary": "Robbins LLP has reminded investors of a class action lawsuit filed against POMDoctor, Ltd. (NASDAQ: POM) concerning a \"pump-and-dump\" scheme. The lawsuit alleges that POMDoctor's stock price surged before its IPO due to a social media-orchestrated scheme involving false claims an", "url": "https://www.gurufocus.com/news/8603962/pom-stockholder-alert-robbins-llp-reminds-investors-of-the-class-action-against-pomdoctor-ltd?mobile=true%3Fmobile%3Dtrue&mobile=true%3Fmobile%3Dtrue%3Fmobile%3Dtrue&mobile=true&mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-08T19:10:15", "published_display": "08 Jun 2026 19:10", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM Should I Buy", "summary": "An analysis suggests that PomDoctor Ltd (POM) is not a good buy for long-term investors. The stock exhibits weak technical momentum, negative news sentiment regarding an ADS ratio change, and a lack of strong fundamental or analyst support. Despite a slight pre-market bounce, the", "url": "https://intellectia.ai/en/stock/POM/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-05-30T05:09:36", "published_display": "30 May 2026 05:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change", "summary": "POMDOCTOR LIMITED (NASDAQ: POM), an online medical services platform in China, announced a plan to change its American Depositary Shares (ADS) ratio. The new ratio will be one ADS representing three Class A ordinary shares, equivalent to a one-for-eighteen reverse ADS split for c", "url": "https://finance.yahoo.com/markets/stocks/articles/pomdoctor-limited-announces-plan-implement-120000188.html", "source_name": "Market source", "published_at": "2026-05-27T19:40:03", "published_display": "27 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM", "summary": "PomDoctor Ltd ADR (POM) closed at $0.1156, up 6.15%. The company, which specializes in online medical services for chronic disease management and pharmaceutical services in China, recently announced its fiscal year 2025 financial results. It has also been focusing on \"AI + Medica", "url": "https://finviz.com/stock?t=POM", "source_name": "Finviz", "published_at": "2026-05-27T01:39:19", "published_display": "27 May 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED - American Depositary Shares (NQ: POM", "summary": "This article provides recent news headlines regarding POMDOCTOR LIMITED (NASDAQ: POM). The news primarily focuses on several law firms announcing class action lawsuits against the company, urging investors to secure counsel. The latest price for POM is also noted as 0.1133, down ", "url": "https://markets.financialcontent.com/stocks/quote/news?Language=english%2F1000&ChannelType=PRESSRELEASES&CurrentPage=1&Symbol=NQ%3APOM", "source_name": "FinancialContent", "published_at": "2026-05-15T08:40:26", "published_display": "15 May 2026 08:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (NasdaqGM:POM) Stock Price", "summary": "Pomdoctor Limited (NasdaqGM:POM) has a market capitalization of US$13.4 million, with its stock price down 97.19% over the past year. The company recently announced a strategic upgrade focusing on AI and medical-grade smart wearables for chronic disease management, despite facing", "url": "https://simplywall.st/stock/nasdaqgm/pom", "source_name": "Simply Wall Street", "published_at": "2026-05-14T21:40:47", "published_display": "14 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pomdoctor-limited-announces-fiscal-2025-203000278.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:30:00+00:00", "published_display": "14 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR : Announces Fiscal Year 2025 Financial Results", "summary": "POMDOCTOR Limited announced its financial results for fiscal year 2025, reporting a 16.7% increase in net revenues to RMB399.9 million, driven largely by its Internet hospital business and online pharmacy sales. Despite a net loss of RMB130.9 million, primarily due to IPO-related", "url": "https://www.marketscreener.com/news/pomdoctor-announces-fiscal-year-2025-financial-results-ce7f5bd2d989f221", "source_name": "www.marketscreener.com", "published_at": "2026-05-14T21:10:58", "published_display": "14 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A Company Profile & Introduction", "summary": "This article provides a company profile and introduction for POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A. Details about its operations and market position are typically covered in such profiles.", "url": "https://www.moomoo.com/stock/POM-US/company?chain_id=Name1K9-3FXPhg.1kvvik0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A64,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Fprofile%2Feric-%E3%81%AE-%E8%B4%A2%E5%BA%93-102621613%22%7D", "source_name": "Moomoo", "published_at": "2026-05-11T20:09:14", "published_display": "11 May 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd POM", "summary": "This page provides an overview of PomDoctor Ltd (POM), including its current stock price of $0.155, which is up 106.67%. It also shows the company's market capitalization and offers sections for financial data, discussions, and analysis. The quotes are delayed by 15 minutes, and ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/comments", "source_name": "TradingKey", "published_at": "2026-05-11T16:39:54", "published_display": "11 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (Nasdaq:POM) - Stock Analysis", "summary": "This Simply Wall St report provides a stock analysis of Pomdoctor (Nasdaq: POM), highlighting its market capitalization of US$58.5 million and a share price of US$0.075. The company recently announced a strategic upgrade focusing on AI and medical-grade smart wearables for chroni", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor", "source_name": "Simply Wall Street", "published_at": "2026-05-08T06:09:54", "published_display": "08 May 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Limited Delays Annual 20-F Filing", "summary": "PomDoctor Limited has announced a delay in filing its annual Form 20-F for the year ended December 31, 2025, due to needing more time to finalize its consolidated financial statements. The company expects to file within 15 calendar days of the original due date and does not antic", "url": "https://www.theglobeandmail.com/investing/markets/stocks/POM/pressreleases/1647287/pomdoctor-limited-delays-annual-20-f-filing/", "source_name": "The Globe and Mail", "published_at": "2026-05-01T08:28:00", "published_display": "01 May 2026 08:28", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR Ltd (POM) director Bao Wenqing files initial ownership report", "summary": "POMDOCTOR Ltd (POM) director Bao Wenqing has filed an initial ownership report (Form 3) indicating beneficial ownership of company securities. The filing shows no reported stock transactions or derivative positions, with the transaction summary specifying zero buys, sells, exerci", "url": "https://www.stocktitan.net/sec-filings/POM/form-3-pomdoctor-ltd-initial-statement-of-beneficial-ownership-b98479d1ee94.html", "source_name": "Stock Titan", "published_at": "2026-05-01T03:09:46", "published_display": "01 May 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading", "summary": "", "url": "https://finance.yahoo.com/markets/world-indices/articles/asian-equities-traded-us-american-145744953.html", "source_name": "MT Newswires", "published_at": "2026-04-28T14:57:44+00:00", "published_display": "28 Apr 2026 14:57", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR (POM) names HYYH CPA LLC as new independent auditor", "summary": "POMDOCTOR Limited has appointed HYYH CPA LLC as its new independent registered public accounting firm, replacing Marcum Asia CPAs LLP, for the audit of its 2025 consolidated financial statements. The company stated there were no disagreements with Marcum regarding accounting prin", "url": "https://www.stocktitan.net/sec-filings/POM/6-k-pomdoctor-ltd-current-report-foreign-issuer-997bf02c0764.html", "source_name": "Stock Titan", "published_at": "2026-04-21T10:40:17", "published_display": "21 Apr 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Limited Replaces Marcum Asia With HYYH CPA as Auditor", "summary": "PomDoctor Limited has replaced Marcum Asia CPAs LLP with HYYH CPA LLC as its independent auditor for the audit of its 2025 consolidated financial statements. The change, approved by the board and audit committee, occurred without reported disputes, though previously disclosed mat", "url": "https://www.tipranks.com/news/company-announcements/pomdoctor-limited-replaces-marcum-asia-with-hyyh-cpa-as-auditor", "source_name": "TipRanks", "published_at": "2026-04-20T20:10:32", "published_display": "20 Apr 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy POM Stock After the PomDoctor IPO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWEhyMkxKc2hTQUh4QlJQc0w4dy1fUV9aR2ZGeFp1TXZsR1FJdmFZNnluUXZPNGRrMmZjb290NURxNWNHVVdsUzN4SmJaNTExSU02Ykhna2pHOFN1MzVULTc2TXhKazZObGtfa1QwRDV0dzlGM1p0Y09UWGppek9WQnR0UzdCRldqVUZSVFFLeGxhTGFzb3laLQ?oc=5", "source_name": "Barchart", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor closes $20M IPO to grow mobile health platform in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONlk1TGlFVEllQlZmSjVOdzRzQkxOTmpOLXV2TnBONW9td1M1NGk5V3cwcmV2anZwOW15RlFzdTZKOXFKMy1yektHZ1JoVkt0RkdjcVg2S0NJeUJuT2NZWWtqdnhkMTJlM2Y1U1RRZHVxT1ZEaE5zczBoVGlfRjhBbzZsSkdYdVpHLWc0T2FLSUwtZ0I0aXE2ZXlFYUxaR2VicUpLNHBGRFc?oc=5", "source_name": "BioWorld News", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Closing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxONnBtX3VQTFFaaTU3Y21iaXNvdUZiczIycjl3Y2hTN1M4SWxrZk84RVJXZWtvWFZJOE9PSENpZkZ5NEh4dWpDUlFSSTdzelo0ZFplb2duSGVMZ2hMdkVob3g4Tm1qckdLZjYxQUZwLThLOHNJQnJ4dmdMY1VuUERWaU43MUVoemUyT0Y0Tl9wdi1SRDg?oc=5", "source_name": "Market source", "published_at": "2025-10-09T07:00:00+00:00", "published_display": "09 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-limited-advances-healthcare-data-120000932.html", "source_name": "PR Newswire", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED (POM) expands AI-powered chronic disease data platform", "summary": "POMDOCTOR LIMITED is strengthening its AI-powered chronic disease management platform by building a comprehensive healthcare data ecosystem. The company leverages real-world data from wearables, remote monitoring, and patient interactions to improve AI models and provide personal", "url": "https://www.stocktitan.net/sec-filings/POM/6-k-pomdoctor-ltd-current-report-foreign-issuer-d6275cf75d23.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:13:36", "published_display": "15 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor Connects Wearables, Doctors and Health Data for AI Care", "summary": "Pomdoctor (NASDAQ: POM) is advancing its healthcare data strategy to enhance AI-powered chronic disease management by integrating real-world data from various sources including wearables, remote patient monitoring systems, and physician interactions. The company aims to build a c", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-advances-healthcare-data-asset-strategy-to-cs4d7f9ibyak.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:13:36", "published_display": "15 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor Says It Has Regained Compliance with Nasdaq Minimum Bid Price Rule", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-says-regained-compliance-nasdaq-134033773.html", "source_name": "MT Newswires", "published_at": "2026-07-13T13:40:33+00:00", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor regains compliance with Nasdaq minimum bid price rule", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQcmdpRlZ5QXJBY1RlUDRWUDNoZ3diMS1Ha1J6N0h2TW5Ha05sYm51LWZuX1lPTHN3Z3JvM1d1TTd4bmFxeWRTeTVpTFd2X3Z0dmhqYmlhNWJ4WGRSLVg5UlBGZE9Bdmc5V3kxU0NKSGZ5RnpZdm95bGc0T1lKSUwtc1hydGZ4LWNEOVBFaFdGTURtTHQwS2pLT3ZMRGpXUGJGRThLMEhUMkQtVVY4SXhPY3BrdjZaTTZVYmdESQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-13T12:11:56+00:00", "published_display": "13 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement", "summary": "POMDOCTOR LIMITED (NASDAQ: POM) announced its regaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This follows a previous notification on January 29, 2026, when the company's American Depositary Shares fell below the threshold. The stock has since", "url": "https://finance.yahoo.com/markets/stocks/articles/pomdoctor-limited-regains-compliance-nasdaq-120000205.html", "source_name": "Market source", "published_at": "2026-07-13T12:09:52", "published_display": "13 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com", "summary": "Pomdoctor Limited has regained compliance with Nasdaq's minimum bid price requirement after its American Depositary Shares maintained a closing bid price of $1.00 or higher for 10 consecutive business days. The company had previously received a deficiency notice in January 2026. ", "url": "https://ca.investing.com/news/stock-market-news/pomdoctor-regains-compliance-with-nasdaq-minimum-bid-price-rule-93CH-4731049", "source_name": "Investing.com Canada", "published_at": "2026-07-13T12:09:52", "published_display": "13 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/pomdoctor-limited-continues-advance-ai-120000708.html", "source_name": "PR Newswire", "published_at": "2026-07-09T12:00:00+00:00", "published_display": "09 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor pushes AI-powered chronic disease monitoring with wearables", "summary": "POMDOCTOR (NASDAQ: POM) has announced its continued advancement in AI-enabled chronic disease management, integrating AI analytics, remote patient monitoring, and wearables to create a predictive, continuous, and personalized healthcare ecosystem. The company highlights the signi", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-continues-to-advance-ai-enabled-chronic-disease-aja11bf6o303.html", "source_name": "Stock Titan", "published_at": "2026-07-09T11:39:41", "published_display": "09 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of POMDOCTOR LIMITED \u2013 NASDAQ:POM", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQal9NaUtRV3NUWklWZUJ4MjNKbGhYS1JKSU5GbFRjLWFESE5sVjZqbmhoMllMUklORktMRW5jRG1Ld1J3UnFuT0dpczNmcENQR0lrMk5BWWdNM0pCNEx1VHZ6MWlMYW9RV2Q0QTZnMEtjRnpwMWphZWEyOWdHdENnR24xVnBsUlRQTlpRTURFeXhKUjZ6Mko5eEJNczgyaEkzMkJOY1Zn?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:15:02+00:00", "published_display": "04 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services", "summary": "POMDOCTOR LIMITED (NASDAQ: POM) has announced a strategic upgrade, repositioning itself as a foundational infrastructure provider for predictive healthcare data and services. The company aims to evolve from a traditional online healthcare platform to an AI-enabled ecosystem that ", "url": "https://www.manilatimes.net/2026/07/02/tmt-newswire/pr-newswire/pomdoctor-limited-announces-strategic-upgrade-toward-infrastructure-for-predictive-healthcare-data-and-services/2377494/amp", "source_name": "The Manila Times", "published_at": "2026-07-02T18:09:14", "published_display": "02 Jul 2026 18:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce", "summary": "Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and its officers. The lawsuit alleges that PomDoctor engaged in a fraudulent stock promotion scheme involving misinformation and coordinated dumping of shares by insiders", "url": "https://natlawreview.com/press-releases/pom-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-pomdoctor-4", "source_name": "The National Law Review", "published_at": "2026-07-01T05:10:30", "published_display": "01 Jul 2026 05:10", "sentiment": "negative", "sentiment_pct": 10, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for PomDoctor Ltd (POM) for FY2024 and FY2023, categorized by business segment. It details the proportion of revenue generated from prescription drugs, over-the-counter medicines, traditional Chinese medicine, online consultation, and med", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:20", "published_display": "18 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of PomDoctor Ltd's (POM) dividend and stock split history. It notes that no dividends have been distributed by the company over the past five years. The only recorded stock split event for POM is a 18-to-1 merger on May 28, 2026.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:36", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor to implement 1-for-18 reverse ADS split June 22 By Investing.com", "summary": "Pomdoctor Limited announced a 1-for-18 reverse American Depositary Share (ADS) split, effective June 22, 2026. This action will change the ADS ratio from one ADS representing one-sixth of a Class A ordinary share to one ADS representing three Class A ordinary shares. The reverse ", "url": "https://za.investing.com/news/stock-market-news/pomdoctor-to-implement-1for18-reverse-ads-split-june-22-93CH-4332380", "source_name": "Investing.com South Africa", "published_at": "2026-06-17T23:40:49", "published_display": "17 Jun 2026 23:40", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Institutional Confidence", "summary": "This article provides an \"Institutional Confidence\" score for PomDoctor Ltd (POM), detailing shares held by various institutions like XTX Markets LLC, Millennium Management LLC, and UBS Financial Services, Inc. It shows a previous score of 0.00 with no change, indicating a stable", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T11:39:53", "published_display": "17 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd (POM) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of PomDoctor Ltd (POM), noting the current stock price, market capitalization, and the lack of disclosed relevant data for key valuation metrics such as P/E, P/B, P/S, and P/CF ratios. It highlights that the company has not yet provided ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T11:39:53", "published_display": "17 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSTNfd0Y1M3VRT2JZSnU3ZjUxdXpmVFplMVRVZWFwdHY2blJfMEh3WElKZXFTTGNSamlhZkFuVUR4MHdPbGYyR2tkM0VSamFZRTdXdklhRHVsU0hxTm5zeU9YSHd5V3FDcHRHS1VyVGhiaWVXQTZsYjJ1c2hFQ2hDWWJXMHB2UU8wUjZYZm5KRUR0WUlsRUZrSkRhVjhJOWRoTTlxUw?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor to implement 1-for-18 reverse ADS split June 22", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOWUs3VDRZWWxSNEpmR1ctWm5qTHl5SmRUNmZWWWVVdm55bndNN1V4RzNGRkxlaWdfTVJGdHhQbUI5MnFlckVTNGRkTnpNRmpfbnk5cTZ4OEduYTBfaUVfU2lEdGROX09QQ0pxaEx3RlUzeEtLdVJmdTkwcktiaWtUcjE1ZV9yUzVqNmZEdnQ3LVNsSEVuUFQxVWwwQ1o0M21JYkdFeC11dGdqWGZ5Mm4zVF93?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Own Pomdoctor ADSs? 18 old shares will become 1 on June 22", "summary": "POMDOCTOR (NASDAQ:POM) has announced that its ADS-to-Class A ordinary share ratio will change effective June 22, 2026. This adjustment means that 18 existing ADSs will be consolidated into 1 new ADS, effectively a one-for-eighteen reverse ADS split. The change will happen automat", "url": "https://www.stocktitan.net/news/POM/pomdoctor-limited-announces-ads-ratio-change-to-be-effective-on-june-v7k6q8fecld4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T04:10:02", "published_display": "16 Jun 2026 04:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM Stockholder Alert: Robbins LLP Reminds Investors of the Clas", "summary": "Robbins LLP has reminded investors of a class action lawsuit filed against POMDoctor, Ltd. (NASDAQ: POM) concerning a \"pump-and-dump\" scheme. The lawsuit alleges that POMDoctor's stock price surged before its IPO due to a social media-orchestrated scheme involving false claims an", "url": "https://www.gurufocus.com/news/8603962/pom-stockholder-alert-robbins-llp-reminds-investors-of-the-class-action-against-pomdoctor-ltd?mobile=true%3Fmobile%3Dtrue&mobile=true%3Fmobile%3Dtrue%3Fmobile%3Dtrue&mobile=true&mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-08T19:10:15", "published_display": "08 Jun 2026 19:10", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM Should I Buy", "summary": "An analysis suggests that PomDoctor Ltd (POM) is not a good buy for long-term investors. The stock exhibits weak technical momentum, negative news sentiment regarding an ADS ratio change, and a lack of strong fundamental or analyst support. Despite a slight pre-market bounce, the", "url": "https://intellectia.ai/en/stock/POM/should-i-buy", "source_name": "Intellectia AI", "published_at": "2026-05-30T05:09:36", "published_display": "30 May 2026 05:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change", "summary": "POMDOCTOR LIMITED (NASDAQ: POM), an online medical services platform in China, announced a plan to change its American Depositary Shares (ADS) ratio. The new ratio will be one ADS representing three Class A ordinary shares, equivalent to a one-for-eighteen reverse ADS split for c", "url": "https://finance.yahoo.com/markets/stocks/articles/pomdoctor-limited-announces-plan-implement-120000188.html", "source_name": "Market source", "published_at": "2026-05-27T19:40:03", "published_display": "27 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POM", "summary": "PomDoctor Ltd ADR (POM) closed at $0.1156, up 6.15%. The company, which specializes in online medical services for chronic disease management and pharmaceutical services in China, recently announced its fiscal year 2025 financial results. It has also been focusing on \"AI + Medica", "url": "https://finviz.com/stock?t=POM", "source_name": "Finviz", "published_at": "2026-05-27T01:39:19", "published_display": "27 May 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED - American Depositary Shares (NQ: POM", "summary": "This article provides recent news headlines regarding POMDOCTOR LIMITED (NASDAQ: POM). The news primarily focuses on several law firms announcing class action lawsuits against the company, urging investors to secure counsel. The latest price for POM is also noted as 0.1133, down ", "url": "https://markets.financialcontent.com/stocks/quote/news?Language=english%2F1000&ChannelType=PRESSRELEASES&CurrentPage=1&Symbol=NQ%3APOM", "source_name": "FinancialContent", "published_at": "2026-05-15T08:40:26", "published_display": "15 May 2026 08:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (NasdaqGM:POM) Stock Price", "summary": "Pomdoctor Limited (NasdaqGM:POM) has a market capitalization of US$13.4 million, with its stock price down 97.19% over the past year. The company recently announced a strategic upgrade focusing on AI and medical-grade smart wearables for chronic disease management, despite facing", "url": "https://simplywall.st/stock/nasdaqgm/pom", "source_name": "Simply Wall Street", "published_at": "2026-05-14T21:40:47", "published_display": "14 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pomdoctor-limited-announces-fiscal-2025-203000278.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:30:00+00:00", "published_display": "14 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR : Announces Fiscal Year 2025 Financial Results", "summary": "POMDOCTOR Limited announced its financial results for fiscal year 2025, reporting a 16.7% increase in net revenues to RMB399.9 million, driven largely by its Internet hospital business and online pharmacy sales. Despite a net loss of RMB130.9 million, primarily due to IPO-related", "url": "https://www.marketscreener.com/news/pomdoctor-announces-fiscal-year-2025-financial-results-ce7f5bd2d989f221", "source_name": "www.marketscreener.com", "published_at": "2026-05-14T21:10:58", "published_display": "14 May 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A Company Profile & Introduction", "summary": "This article provides a company profile and introduction for POMDOCTOR LIMITED SPON ADS EACH REP 0.16 CL A. Details about its operations and market position are typically covered in such profiles.", "url": "https://www.moomoo.com/stock/POM-US/company?chain_id=Name1K9-3FXPhg.1kvvik0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A64,%22f%22%3A%22www.moomoo.com%2Fcommunity%2Fprofile%2Feric-%E3%81%AE-%E8%B4%A2%E5%BA%93-102621613%22%7D", "source_name": "Moomoo", "published_at": "2026-05-11T20:09:14", "published_display": "11 May 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Ltd POM", "summary": "This page provides an overview of PomDoctor Ltd (POM), including its current stock price of $0.155, which is up 106.67%. It also shows the company's market capitalization and offers sections for financial data, discussions, and analysis. The quotes are delayed by 15 minutes, and ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pom/comments", "source_name": "TradingKey", "published_at": "2026-05-11T16:39:54", "published_display": "11 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (Nasdaq:POM) - Stock Analysis", "summary": "This Simply Wall St report provides a stock analysis of Pomdoctor (Nasdaq: POM), highlighting its market capitalization of US$58.5 million and a share price of US$0.075. The company recently announced a strategic upgrade focusing on AI and medical-grade smart wearables for chroni", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor", "source_name": "Simply Wall Street", "published_at": "2026-05-08T06:09:54", "published_display": "08 May 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Limited Delays Annual 20-F Filing", "summary": "PomDoctor Limited has announced a delay in filing its annual Form 20-F for the year ended December 31, 2025, due to needing more time to finalize its consolidated financial statements. The company expects to file within 15 calendar days of the original due date and does not antic", "url": "https://www.theglobeandmail.com/investing/markets/stocks/POM/pressreleases/1647287/pomdoctor-limited-delays-annual-20-f-filing/", "source_name": "The Globe and Mail", "published_at": "2026-05-01T08:28:00", "published_display": "01 May 2026 08:28", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR Ltd (POM) director Bao Wenqing files initial ownership report", "summary": "POMDOCTOR Ltd (POM) director Bao Wenqing has filed an initial ownership report (Form 3) indicating beneficial ownership of company securities. The filing shows no reported stock transactions or derivative positions, with the transaction summary specifying zero buys, sells, exerci", "url": "https://www.stocktitan.net/sec-filings/POM/form-3-pomdoctor-ltd-initial-statement-of-beneficial-ownership-b98479d1ee94.html", "source_name": "Stock Titan", "published_at": "2026-05-01T03:09:46", "published_display": "01 May 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading", "summary": "", "url": "https://finance.yahoo.com/markets/world-indices/articles/asian-equities-traded-us-american-145744953.html", "source_name": "MT Newswires", "published_at": "2026-04-28T14:57:44+00:00", "published_display": "28 Apr 2026 14:57", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR (POM) names HYYH CPA LLC as new independent auditor", "summary": "POMDOCTOR Limited has appointed HYYH CPA LLC as its new independent registered public accounting firm, replacing Marcum Asia CPAs LLP, for the audit of its 2025 consolidated financial statements. The company stated there were no disagreements with Marcum regarding accounting prin", "url": "https://www.stocktitan.net/sec-filings/POM/6-k-pomdoctor-ltd-current-report-foreign-issuer-997bf02c0764.html", "source_name": "Stock Titan", "published_at": "2026-04-21T10:40:17", "published_display": "21 Apr 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PomDoctor Limited Replaces Marcum Asia With HYYH CPA as Auditor", "summary": "PomDoctor Limited has replaced Marcum Asia CPAs LLP with HYYH CPA LLC as its independent auditor for the audit of its 2025 consolidated financial statements. The change, approved by the board and audit committee, occurred without reported disputes, though previously disclosed mat", "url": "https://www.tipranks.com/news/company-announcements/pomdoctor-limited-replaces-marcum-asia-with-hyyh-cpa-as-auditor", "source_name": "TipRanks", "published_at": "2026-04-20T20:10:32", "published_display": "20 Apr 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy POM Stock After the PomDoctor IPO?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWEhyMkxKc2hTQUh4QlJQc0w4dy1fUV9aR2ZGeFp1TXZsR1FJdmFZNnluUXZPNGRrMmZjb290NURxNWNHVVdsUzN4SmJaNTExSU02Ykhna2pHOFN1MzVULTc2TXhKazZObGtfa1QwRDV0dzlGM1p0Y09UWGppek9WQnR0UzdCRldqVUZSVFFLeGxhTGFzb3laLQ?oc=5", "source_name": "Barchart", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pomdoctor closes $20M IPO to grow mobile health platform in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONlk1TGlFVEllQlZmSjVOdzRzQkxOTmpOLXV2TnBONW9td1M1NGk5V3cwcmV2anZwOW15RlFzdTZKOXFKMy1yektHZ1JoVkt0RkdjcVg2S0NJeUJuT2NZWWtqdnhkMTJlM2Y1U1RRZHVxT1ZEaE5zczBoVGlfRjhBbzZsSkdYdVpHLWc0T2FLSUwtZ0I0aXE2ZXlFYUxaR2VicUpLNHBGRFc?oc=5", "source_name": "BioWorld News", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "POMDOCTOR LIMITED Announces Closing of Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxONnBtX3VQTFFaaTU3Y21iaXNvdUZiczIycjl3Y2hTN1M4SWxrZk84RVJXZWtvWFZJOE9PSENpZkZ5NEh4dWpDUlFSSTdzelo0ZFplb2duSGVMZ2hMdkVob3g4Tm1qckdLZjYxQUZwLThLOHNJQnJ4dmdMY1VuUERWaU43MUVoemUyT0Y0Tl9wdi1SRDg?oc=5", "source_name": "Market source", "published_at": "2025-10-09T07:00:00+00:00", "published_display": "09 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 40, "sentiment_summary": {"positive": 8, "negative": 10, "neutral": 22, "score": 48, "total": 40, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 14.3, "count": 26}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 8, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 1.53, "latest_week": "2026-07-10", "one_week_move": -4.4, "four_week_move": -16.3, "twelve_week_move": -78.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.260397, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -93.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.8333, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.4% over one week, -16.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 6}, {"label": "TradingKey", "count": 5}, {"label": "Market source", "count": 4}, {"label": "PR Newswire", "count": 3}, {"label": "MT Newswires", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Simply Wall Street", "count": 2}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 40}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Analyst action", "count": 4}, {"label": "Earnings", "count": 4}, {"label": "Regulatory and legal", "count": 3}, {"label": "Macro sensitivity", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "40", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.4% over one week, -16.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities"}], "updated_at": "2026-07-16T11:42:30.038766+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}